Male cancer drug hits cost block
7th Nov 2005, 18:03 GMT
Men in Scotland with prostrate cancer will not receive a life-prolonging drug on the NHS because it is too expensive.
Male cancer drug hits cost block related news:
- Onyx Pharma up; cancer drug may boost survival rate — SacBee -- Business
- Male Breast Cancer Foundation Celebrates 10th Birthday — PR Web (The Free Wire Service) Lifestyle Health and Fitness
- Lung cancer drug approved for treating pancreatic cancer — News-Medical News Feed
- Safer drug than tamoxifen found for fighting breast cancer — KeralaNext: Health
- Tarceva gets FDA go-ahead for pancreatic cancer treatment — The Earth Times Online Newspaper
- Research unveils new, reliable approach to drug delivery for cancer patients — EurekAlert! - Cancer
- Breast Cancer Patients Testing Powerful Drug — NBC 17 - Health
- FDA approves Genentech drug in combo use — bizjournals.com Health Care:Pharmaceuticals headlines
- Blair gives cancer drug approval — BBC News | England | UK Edition
- Colon-cancer drug success — RSS Top Stories -- SiliconValley.com
Latest news from BBC News | Latest Published Stories | World Edition:
- Under the thumb?
- Police name bridge fall pensioner
- No link 'between R&D and sales'
- New drink-drive campaign launched
- Iran key as Israeli PM meets Bush
- Community centre project praised
- Tributes to tractor crash victim
- Air guitar T-shirt rocks for real
- Annual thong run turns more heads
- 'Tragic' OAP killed beloved wife